You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
04
Apr 24
Analysts’ Conference
10
Roadshow
08
May 24
Conference Call
Publication quarterly statement (call-date Q1)
13
17
Annual General Meeting
09
Aug 24
Publication half-yearly financial statements
21
07
Nov 24
Publication quarterly statement (call-date Q3)
25
28
Mar 24
Publication of Annual Report
06
Feb 24
Nov 23
Press Release – quarterly statement (call-date Q3)
Nov
2023
Sep 23
24
Aug 23
Jun
15
May 23
12
Press Release – quarterly statement (call-date Q1)
Apr 23
30
Mar 23
Press Release for Annual Report
Nov 22
Oct
2022
05
Sep 22
Aug 22
11
29
Jun 22
18
May 22
May
Mar 22
03
22
Nov 21
Sep 21
Sep
2021
26
Aug 21
Jul 21
Press Release – half-yearly financial statements
28 March 2024
APONTIS PHARMA expects profitable growth again in 2024
6 February 2024
APONTIS PHARMA successfully completes performance and efficiency improvement program
9 November 2023
APONTIS PHARMA presents details of the restructuring and efficiency program – Nine-month figures for 2023 and new sales and earnings forecast for 2023 published
8 November 2023
APONTIS PHARMA AG with new forecast 2023 and details on announced restructuring program
10 August 2023
APONTIS PHARMA confirms preliminary figures – H1 2023 sales and earnings decline
31 July 2023
APONTIS PHARMA: Co-promotion contract with AstraZeneca not to be continued in 2024
Annual financial statements 2023
Half-yearly financial statements 2023
30 March 2023
Annual financial statements 2022
9 February 2024
Original-Research: APONTIS PHARMA AG (von Montega AG): Kaufen
14 November 2023
12 July 2023
10 May 2023
4 May 2023